Although you pay to use the Facility, the full cost of any scientific core facility is not passed on to the end user.
The Faculty of Medical Sciences look at the quantity and quality of publications from the University research themes containing data with direct links to the FCCF usage. This is used as a metric of facility performance (alongside the number of usage hours and cost recovery).
Acknowledging FCCF in your papers, posters and talks you will help to ensure we continue to receive faculty subsidy and continue to offer excellent access rates.
Using data generated within FCCFUsing data generated within FCCF
In a publication that includes data (main figures or supplemental) generated within the FCCF, please state:
“We acknowledge the Newcastle University Flow Cytometry Core Facility (FCCF) for assistance with the generation of Flow Cytometry data”
Working closely with FCCF team membersWorking closely with FCCF team members
If a member of the FCCF team has worked closely with you on a project, you should acknowledge this.
It is good practice to include their name in the acknowledgement section at least.
In situations where they have made substantial intellectual input, you can offer them a co-authorship. This should be discussed at the earliest opportunity.
Using our logoUsing our logo
You can use our logo in a talk or a poster for a conference. This is intended to be for acknowledgement purposes.
Download our logo (jpeg: 1MB).
Paragraph for grant supportParagraph for grant support
“All the Flow Cytometry outlined in this grant proposal will be conducted using systems that are located in the Newcastle University Flow Cytometry Core Facility (FCCF). The instruments are maintained to a very high standard by a team of specialists led by Dr Andrew Filby. Dr Filby is an expert in cytometry applications and method development with over 15 years’ experience in the field. He is also recognised by the International Society for the Advancement of Cytometry (ISAC) as an “Emerging Leader” in the core facility network. Particular attention is paid by Dr Filby and his team to minimising/eliminating sources of potentially confounding measurement error through tracking of instrument performance and the use of the correct biological controls. Furthermore the facility will train and support users in all aspects of cytometry including panel design, sample preparation, sample acquisition, data analysis and data interpretation. The facility also actively encourages adherence to the “MIFlowCyte” minimum information standards about flow cytometry experimentation”.